ECSS
IONS icon

Eurizon Capital SGR SpA’s Ionis Pharmaceuticals IONS Stock Holding History

Eurizon Capital SGR SpA’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
3,639
+125
+4% +$9.41K ﹤0.01% 692
2026
Q1 		$256K Buy
3,514
+200
+6% +$15.8K ﹤0.01% 713
2025
Q4 		$261K Buy
+3,314
New +$250K ﹤0.01% 628

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Eurizon Capital SGR SpA's IONS Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Ionis Pharmaceuticals (IONS) stake by 3.6% in Q2 2026, buying an estimated $9.41K and bringing the position to 3,639 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Eurizon Capital SGR SpA first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Eurizon Capital SGR SpA held 3,639 shares of Ionis Pharmaceuticals worth $294K as of Q2 2026.
  • Eurizon Capital SGR SpA bought 125 Ionis Pharmaceuticals shares in Q2 2026, an estimated $9.41K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #692 holding.
  • Eurizon Capital SGR SpA first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.